We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |


JAMA. 1954;154(15):1274-1277. doi:10.1001/jama.1954.02940490038010.
Text Size: A A A
Published online


Herrmann, J. B., and Adair, F. E.:  Effect of Testosterone Propionate on Carcinoma of Female Breast with Soft Tissue Metastases , J. Clin. Endocrinol. 6:769-775 ( (Dec.) ) 1946.
Link to Article[[XSLOpenURL/10.1210/jcem-6-12-769]]
Herrmann, J. B.; Adair, F. E., and Woodward, H. Q.:  Use of Testosterone Propionate in Treatment of Advanced Carcinoma of Breast: II. Treatment of Osseous Metastases , Surgery 22: 101-119 ( (July) ) 1947.
 Current Status of Hormone Therapy of Advanced Mammary Cancer, report of the Council on Pharmacy and Chemistry , J. A. M. A. 146: 471-477 ( (June 2) ) 1951.
Link to Article[[XSLOpenURL/10.1001/jama.1951.03670050053011]]
Herrmann, J. B.; Kirsten, E., and Krakauer, J. S.:  Hypercalcemic Syndrome Associated with Androgenic and Estrogenic Therapy , J. Clin. Endocrinol. 9:1-12 ( (Jan.) ) 1949.
Link to Article[[XSLOpenURL/10.1210/jcem-9-1-1]]
Werner, S. C.; Hanger, F. M., and Kritzler, R. A.:  Jaundice During Methyl Testosterone Therapy , Am. J. Med. 8:325-331 ( (March) ) 1950.
Link to Article[[XSLOpenURL/10.1016/0002-9343(50)90065-9]]
Segaloff, A., and others:  Hormonal Therapy in Cancer of Breast: II. Effect of Methylandrostenediol on Clinical Course and Hormonal Excretion , Cancer 5:271-274 ( (March) ) 1952.
Link to Article[[XSLOpenURL/10.1002/(ISSN)1097-0142]]
The Council on Pharmacy and Chemistry of the American Medical Association has adopted the generic designation stanolone, also known as dihydrotestosterone, androstanolone, androstane-17-(β)-ol-3-one, and Neodrol.
Escher, G. C., and others: Newer Steroids in the Treatment of Advanced Mammary Carcinoma, in Symposium on Steroids in Experimental and Clinical Practice , edited by A. White, Philadelphia, Blakiston Company, 1951, pp. 375-378.
Farrow, J. H., and others:  Evaluation of Androstane-17-(β)-ol-3-one in Treatment of Advanced Mammary Carcinoma , Proc. Am. A. Cancer Res. 1:16 ( (April) ) 1953.
Escher, G. C., and others:  Dihydrotestosterone (Androstanolone) Therapy of Advanced Mammary Carcinoma , read before the American Federation for Clinical Research, Southern Section, New Orleans, Jan. 30, 1953 , to be published.
Herrmann, J. B.: Unpublished data.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.